Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2005-08-02
2005-08-02
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S649000, C514S654000, C514S655000, C514S658000
Reexamination Certificate
active
06924313
ABSTRACT:
The invention relates to substituted tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid trans: protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery disease.
REFERENCES:
patent: 3334017 (1967-08-01), Biel
patent: 3359316 (1967-12-01), Biel
patent: 3711543 (1973-01-01), Bollag et al.
patent: 5306718 (1994-04-01), Lauffer et al.
patent: 5519001 (1996-05-01), Kushwaha et al.
patent: 6063788 (2000-05-01), Brandes et al.
patent: 6448295 (2002-09-01), Sikorski et al.
patent: 6451823 (2002-09-01), Sikorski et al.
patent: 6451830 (2002-09-01), Sikorski et al.
patent: 6455519 (2002-09-01), Sikorski et al.
patent: 6458803 (2002-10-01), Sikorski et al.
patent: 6458849 (2002-10-01), Sikorski et al.
patent: 6458852 (2002-10-01), Sikorski et al.
patent: 6462092 (2002-10-01), Sikorski et al.
patent: 6476057 (2002-11-01), Sikorski et al.
patent: 6476075 (2002-11-01), Sikorski et al.
patent: 6479552 (2002-11-01), Sikorski et al.
patent: 6482862 (2002-11-01), Sikorski et al.
patent: 6521607 (2003-02-01), Sikorski et al.
patent: 6544974 (2003-04-01), Sikorski et al.
patent: 6583183 (2003-06-01), Sikorski et al.
patent: 6586433 (2003-07-01), Sikorski et al.
patent: 6605624 (2003-08-01), Lee et al.
patent: 6677341 (2004-01-01), Sikorski et al.
patent: 6677353 (2004-01-01), Sikorski et al.
patent: 6677375 (2004-01-01), Sikorski et al.
patent: 6677379 (2004-01-01), Sikorski et al.
patent: 6677380 (2004-01-01), Sikorski et al.
patent: 6683099 (2004-01-01), Sikorski et al.
patent: 6683113 (2004-01-01), Sikorski et al.
patent: 6688382 (2004-02-01), Sikorski et al.
patent: 6696472 (2004-02-01), Sikorski et al.
patent: 6699898 (2004-03-01), Sikorski et al.
patent: 6710089 (2004-03-01), Sikorski et al.
patent: 6723752 (2004-04-01), Sikorski et al.
patent: 6723753 (2004-04-01), Sikorski et al.
patent: 6765023 (2004-07-01), Sikorski et al.
patent: 6787570 (2004-09-01), Sikorski et al.
patent: 6794396 (2004-09-01), Lee et al.
patent: 6803388 (2004-10-01), Sikorski et al.
patent: 441366 (1968-01-01), None
patent: 9627430 (1998-01-01), None
patent: 0442172 (1991-08-01), None
patent: 0314435 (1993-09-01), None
patent: 0801060 (1997-10-01), None
patent: 0796846 (2000-07-01), None
patent: 0818197 (2003-11-01), None
patent: 0818448 (2003-11-01), None
patent: 2305665 (1997-04-01), None
patent: 5320117 (1993-12-01), None
patent: WO9001874 (1990-03-01), None
patent: WO9002113 (1990-03-01), None
patent: WO9738973 (1997-10-01), None
Barter, P. J., et al. High density lipoproteins and coronary heart disease,Atherosclerosis, vol. 121, pp. 1-12 (1996).
Tall, A. R., Plasma cholesteryl ester transfer protein,Journal of Lipid Research, vol. 34, pp. 1255-1274 (1993).
Sirtori, C. R., New Targets for Lipid Lowering and Atherosclerosis Prevention,Pharmac. Ther., vol. 67, No. 3, pp. 433-447 (1995).
Swenson, T. L., et al., Mechanism of Cholesteryl Ester Transfer Protein Inhibition by a Neutralizing Monoclonal Antibody and Mapping of the Monoclonal Antibody Epitope,Journal of Biological Chemistry, vol. 264, No. 24, pp. 14318-14326 (1989).
Morton, R. E., et al., Regulation of lipid transfer between lipoproteins by an endogenous plasma protein: selective inhibition among lipoprotein classes,Journal of Lipid Research, vol. 35, pp. 836-847, (1994).
Pietzonka, T., et al., Phosphonate-containing Analogs of Cholesteryl Ester as Novel Inhibitors of Cholesteryl Ester Transfer Protein,Bioorganic&Medicinal Chemistry Letters, vol. 6, No. 16, PP. 1951-9154 (1996).
Coval, S. J., et al., Wiedendiol-A and -B Cholesteryl Ester Transfer Protein Inhibitors from the Marin SpongeXestospongia Wiedenmayeri, Bioorganic&Medicinal Chemistry Letters, vol. 5, No. 6, pp. 605-610 (1995).
Connolly, D. T., et al., Inactivation of Cholesteryl Ester Transfer Protein by Cysteine Modification,Biochemical&Biophysical Research Communications, vol. 223, pp. 42-47 (1996).
Xia, Y., et al., Substituted 1,3,5-Triazines as Cholesteryl Ester Transfer Protein Inhibitors,Bioorganic&Medicinal Chemistry Letters, vol. 6, No. 7, pp. 919-922 (1996).
Wagaw, S., et al. The Synthesis of Aminopyridines: A Method Employing Palladium-Catalyzed Carbon-Nitrogen Bond Formation,J. Org. Chem., vol. 61, pp. 7240-7241, (1996).
Wolfe, J. P., et al., Improved Functional Group Compatibility in the Palladium-Catalyzed Animation of Aryl Bromides,Tetrahedron Letters, vol. 38, No. 36, pp. 6359-6362 (1997).
Sternbach, D. D., et al., Reduction of O-Acyl Oximes,Tetrahedron Letters, vol. 22, No. 35, pp. 3331-3334, (1981).
Ramachandran, P. V., et al., Chiral Synthesis via Organoboranes. 40. Selective Reductions. 55. A Simple One-Pot Synthesis of the Enantiomers of (Trifluoromethyl)oxirane. A General Synthesis in High Optical Purities of α-Trifluoromethyl Secondary Alcohols via the Ring-Cleavage Reactions of the Epoxide,J. Org. Chem. vol. 60, pp. 41-46, (1995).
Kuo, M. S., et al., Discovery, Isolation, Structure Elucidation, and Biosynthesis of U-106305, a Cholesteryl Ester Transfer Protein Inhibitor from UC 11136,J. Am. Chem. Soc., vol. 117, pp.10629-10634, (1995).
Barrett, A. G. M., et al., Total Synthesis and Stereochemical Assignment of the Quinquecyclopropane-Containing Cholesteryl Ester Transfer Protein Inhibitor U-106305,J. Am. Chem. Soc., vol. 118, pp. 7863-7864 (1996).
McCarthy, P. A., et al., New Approaches to Atherosclerosis: An Overview,Medicinal Research Reviews, vol. 13, No. 2, pp. 139-159, (1993).
Son, Y. C., et a., Purification and Characterization of Human Plasma Proteins that Inhibit Lipid Transfer Activities,Biochimica et Biophysica Acta, vol. 795, pp. 473-480, (1984).
Tollefson, J. H., et al., Regulation of plasma lipid transfer by the high-density lipoproteins,American Physiological Society, pp. E894-E902, (1988).
Lee, J. C., et al., A Cholesteryl Ester Transfer Protein Inhibitor from an Insect-associated Fungus,The Journal of Antibiotics, vol. 49, No. 7, pp. 693-696, (1996).
Busch, S. J., et al., Cholesteryl Ester Analogs Inhibit Cholesteryl Ester but not Triglyceride Transfer Catalyzed by the Plasma Cholesteryl Ester-Triglyceride Transfer Protein,Lipids, vol. 25, No. 4, pp. 216-220 (1990).
Bisgaier, C. L., et al., Cholesteryl Ester Transfer Protein Inhibition by PD 140195,Lipids, vol. 29, No. 12, pp. 811-818, (1994).
Marcoux, J. F., er al., A General Copper-Catalyzed Synthesis of Diaryl Ethers,J. Am. Chem. Soc., vol. 119, pp. 10539-10540, (1997).
Wolfe, J. P., et al., An Improved Catalyst System for Aromatic Carbon-Nitrogen Bond Formation: The Possible Involvement of Bis(Phosphine) Palladium Complexes as Key Intermediates,J. Am. Chem. Soc., vol. 118, pp. 7215-7216, (1996).
Sheradsky, T., et al., Studies on the Preparation of N-Alkyl-O-phenylhydroxylamines,J. Chem. Soc. Perkin Trans., vol. 12, pp. 2781-2781, (1980).
The Systematic Identification of Organic Compounds: A Laboratory Manual, Shriner/Fuson/Curtin, Fifth Edition, copyright 1956 and 1964, John Wiley & Sons, Inc.
Reagents for Organic Synthesis, Feiser & Feiser, vol. 1, copyright 1967, John Wiley & Sons, Inc.
Vogel's Textbook of Practical Organic Chemistry, Fifth Edition, copyright 1989, John Wiley & Sons, Inc., pp. 902-905.
*English language equivalent of CH 441366, 1968.
**English language equivalent of DE 19627430, 1998.
***English language equivalent of JP 05320117, 1993.
Durley Richard C.
Mischke Deborah A.
Parnas Barry L.
Rueppel Melvin L.
Sikorski James A.
Benson Gregg C.
Pfizer Inc.
Raymond Richard L.
Richardson Peter C.
Samuels Lisa A.
LandOfFree
Substituted tertiary-heteroalkylamines useful for inhibiting... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted tertiary-heteroalkylamines useful for inhibiting..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted tertiary-heteroalkylamines useful for inhibiting... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3521657